Bioadaptives, Inc. (BDPT)
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Last price
- $0.00
- As of
Kresmion compiles this page from BDPT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BIOADAPTIVES, INC. (BDPT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-04.
See the full BDPT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BDPT on one page. Preview it with sample data, then open it live with a free account.
Preview the BDPT dossierActive events for BDPT
No recent events on BDPT in the last 180 days.
FREE, NO ACCOUNT
Every event on BDPT, as it fires
New filings, 13F moves and cross asset events on BDPT land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, BDPT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
BDPT's 10-Q filed Aug 19, 2026 states:
The ability to successfully resolve these factors raises substantial doubt about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on BDPT
BDPT against its peers
BDPT's operating margin of -5701.8% ranks in the 8th percentile of 17 Packaged Foods sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.
| Metric | BDPT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 18278 USD | 4.1M USD | 17 | 20 |
| Revenue YoY | 44.3% | -21.0% | 94 | 8 |
| Gross margin | 68.4% | 26.3% | 86 | 17 |
| Operating margin | -5701.8% | -80.9% | 8 | 17 |
| Net margin | -8523.4% | -87.2% | 13 | 19 |
| Return on equity | n/a | -35.6% | n/a | 12 |
Peers (20): NBND, ORISF, RKDA, STKH, TRWD, MEHA, HIGR, ATPC, GPOX, ARRT, TOFB, BSFC, PAVS, WYGC, FAMI, NCRA, CYAN, LIMX, INBP, BABB. Left out: BABYF (no annual filing), CIMG (no annual filing), PSYCF (no annual filing), ABVEF (no annual filing), RTON (period gap). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BDPT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BDPT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BDPT in the last 180 days.
Upstream: SEC EDGAR filings for BDPT
Kresmion, "BIOADAPTIVES, INC. (BDPT) institutional holdings and SEC filings", data as of 2026-11-04, https://kresmion.com/research/BDPT. Upstream data: SEC EDGAR filings for BDPT.
Link to this data (HTML):
<a href="https://kresmion.com/research/BDPT">BIOADAPTIVES, INC. (BDPT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BDPT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BDPT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.